Shareholders Equity and Capital Stock (Details 7) |
3 Months Ended |
|---|---|
|
Mar. 31, 2023
USD ($)
$ / shares
shares
| |
| Warrants | |
| Exercise price | $ / shares | $ 1.46 |
| Number of warrants | shares | 55,830,530 |
| Remaining contractual life (years) | 2 years 3 months 18 days |
| Aggregate Intrinsic Value | $ | $ 0 |
| Exercise price $1.35 | |
| Exercise price | $ / shares | $ 1.35 |
| Number of warrants | shares | 16,730,530 |
| Remaining contractual life (years) | 9 months 18 days |
| Aggregate Intrinsic Value | $ | $ 0 |
| Expiry | Feb. 04, 2024 |
| Exercise price $1.50 | |
| Exercise price | $ / shares | $ 1.50 |
| Number of warrants | shares | 39,100,000 |
| Remaining contractual life (years) | 2 years 10 months 24 days |
| Aggregate Intrinsic Value | $ | $ 0 |
| Expiry | Feb. 21, 2026 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|